Optivise Advisory Services LLC logo

Optivise Advisory Services LLC Portfolio Analytics

Investment Analysis & Holdings Breakdown

Comprehensive portfolio analytics for Optivise Advisory Services LLC with $167.3M in long positions as of Q3 2025, 74% allocated to ETF, and 31% concentrated in top 10 positions.

Portfolio Value
$167.3M
Top 10 Concentration
31%
Top Sector
ETF (74%)
US Exposure
99%
Market Cap Focus
N/A
Countries
4

Composition Analysis

Portfolio breakdown by sector, industry, and market capitalization

Sector Allocation

ETF: 74.10%ETFTechnology: 8.00%Financial Services: 3.00%Consumer Cyclical: 2.80%Communication Services: 2.70%Healthcare: 2.50%Consumer Defensive: 2.40%Industrials: 1.30%Energy: 0.70%Utilities: 0.40%Basic Materials: 0.40%Real Estate: 0.10%
ETF
74.10%
Technology
8.00%
Financial Services
3.00%
Consumer Cyclical
2.80%
Communication Services
2.70%
Healthcare
2.50%
Consumer Defensive
2.40%
Industrials
1.30%
Energy
0.70%
Utilities
0.40%
Basic Materials
0.40%
Real Estate
0.10%

Industry Breakdown

48 industries across all sectors

ETF: 74.13%ETFSoftware - Infrastructure: 2.88%Semiconductors: 2.78%Internet Content & Information: 1.78%Drug Manufacturers - General: 1.67%Consumer Electronics: 1.07%42 more: 14.06%42 more
ETF
ETF
74.13%
Software - Infrastructure
Technology
2.88%
Semiconductors
Technology
2.78%
Internet Content & Information
Communication Services
1.78%
Drug Manufacturers - General
Healthcare
1.67%
Consumer Electronics
Technology
1.07%
Banks - Diversified
Financial Services
0.98%
Specialty Retail
Consumer Cyclical
0.86%
Auto - Manufacturers
Consumer Cyclical
0.84%
Beverages - Non-Alcoholic
Consumer Defensive
0.78%
Discount Stores
Consumer Defensive
0.71%
Telecommunications Services
Communication Services
0.57%

Filter by Sector

Select a sector to filter industries

Market Cap Distribution

Mega Cap (> $200B): 16.37%Mega Cap (> $200B)Large Cap ($10B - $200B): 6.56%Mid Cap ($2B - $10B): 0.89%Small Cap ($300M - $2B): 0.48%Nano Cap (< $50M): 0.23%N/A (ETF or Unknown): 75.46%N/A (ETF or Unknown)
Mega Cap (> $200B)
16.37%
Large Cap ($10B - $200B)
6.56%
Mid Cap ($2B - $10B)
0.89%
Small Cap ($300M - $2B)
0.48%
Nano Cap (< $50M)
0.23%
N/A (ETF or Unknown)
75.46%

Portfolio Concentration

Top 10 Holdings %
31.36%
Top 20 Holdings %
44.49%
Top 50 Holdings %
67.88%
Top 100 Holdings %
85.29%

Geographic Exposure

Portfolio breakdown by country of incorporation

Domestic (US)
99.36%
International
0.641%
Countries
4
Largest Int'l Market
Canada - 0.36%
United States of America
99.36% ($166.3M)
190 holdings
Canada
0.36% ($600.8K)
2 holdings
Israel
0.16% ($264.3K)
1 holdings
Ireland
0.12% ($208.0K)
1 holdings

Holding Behavior

Investment patterns and position management analysis

Portfolio Stability & Commitment

Avg. Top 10
3.5 quarters
Avg. Top 20
4.2 quarters
Avg. All Positions
3.4 quarters
Median Holding Period
5 quarters
Persistence Rate
60.31%
Persistent Holdings Weight
71.04%
Persistent Positions
117
Longest Held
SPDR S&P 500 ETF Trust logo
SPDR S&P 500 ETF TrustSPY - 5 quarters

Position Sizing & Influence

Current Quarter

Avg. New Position
0.33%
Avg. Position Weight
0.52%
Largest Position
iShares Treasury Floating Rate Bond ETF logo
iShares Treasury Floating Rate Bond ETFTFLO - 5.44%
Largest Ownership Stake
Aspire Biopharma Holdings, Inc. Common Stock logo
Aspire Biopharma Holdings, Inc. Common StockASBP - 0.53%
Avg. Ownership Stake
0.002%
Ownership Stake >5%
0
Ownership Stake >1%
0

Historical (Since Q2 2024)

Avg. New Position
0.47%
Avg. Ownership Stake
0.003%
Largest Position
iShares Treasury Floating Rate Bond ETF logo
iShares Treasury Floating Rate Bond ETFTFLO - 17.88% (Q3 2024)
Largest Ownership Stake
Aspire Biopharma Holdings, Inc. Common Stock logo
Aspire Biopharma Holdings, Inc. Common StockASBP - 0.53% (Q3 2025)

Portfolio Turnover

Current Quarter

Turnover Ratio
29.4%
Value Traded
$49.23M
Positions Added
33
Positions Exited
49

Historical (Since Q2 2024)

Avg. Turnover Ratio
24.4%
Avg. Positions Added
49
Avg. Positions Exited
21
Highest Turnover
50.0%
Q2 2024
Lowest Turnover
12.8%
Q2 2025

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.